Cargando…
50P Transcriptomic analysis of host immune response for precision drug prediction for SARS-CoV-2 infected patients: An evidence-based approach
Autor principal: | Bohra, A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Society for Medical Oncology. Published by Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8503654/ http://dx.doi.org/10.1016/j.annonc.2021.08.2046 |
Ejemplares similares
-
Evidence for host-dependent RNA editing in the transcriptome of SARS-CoV-2
por: Di Giorgio, Salvatore, et al.
Publicado: (2020) -
Identification of host transcriptome-guided repurposable drugs for SARS-CoV-1 infections and their validation with SARS-CoV-2 infections by using the integrated bioinformatics approaches
por: Ahmed, Fee Faysal, et al.
Publicado: (2022) -
Poor evidence for host-dependent regular RNA editing in the transcriptome of SARS-CoV-2
por: Zong, Jinbao, et al.
Publicado: (2022) -
Commentary on “Poor evidence for host-dependent regular RNA editing in the transcriptome of SARS-CoV-2”
por: Martignano, F., et al.
Publicado: (2022) -
SARS-CoV-2 and the host-immune response
por: Maison, David P., et al.
Publicado: (2023)